Biomarkers for inflammatory bowel disease: current updates and future outlook / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
;
(12): 712-715, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-712200
ABSTRACT
Inflammatory bowel diseases ( IBD) includes ulcerative colitis ( UC) and Crohn′s disease (CD).Recently, the incidence of IBD in China has been growing rapidly and caused a major public health burden.Although several traditional diagnostic methods can directly evaluate intestinal inflammation in patients with IBD , there are still limitations in these methods such as invasive or unreliable results because of clinical and pathologists′clinical experience .Therefore, there is urgent need for non-invasive, objective and reliable tool for IBD diagnosis or monitoring .With the development of technology and understanding of the pathogenesis of IBD , much progress has been achieved to discover novel IBD biomarkers in genetic , microecological , metabolomics and gut barrier field .In this review , we will demonstrate current updates of IBD related biomarkers and showed future prospective of these biomarkers .
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Laboratory Medicine
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS